Trial site
The University of Tokyo Hospital
- 14running trials
- 8closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Pancreatic cancer4 trials
- Immune thrombocytopenia (ITP)2 trials
- Multiple system atrophy2 trials
- Systemic sclerosis (scleroderma)2 trials
- Childhood cancers1 trial
- Chronic kidney disease1 trial
- Heart failure1 trial
- Liver and biliary tract cancer1 trial
- Macular degeneration1 trial
- Mild cognitive impairment1 trial
- Osteoporosis1 trial
- and 1 more
- Phase
- Phase 314 trials
- Phase 16 trials
- Phase 21 trial
- Status
- Active, not recruiting7 trials
- Completed7 trials
- Recruiting6 trials
- Not yet recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Ono Pharmaceutical Co., Ltd.3 trials
- Takeda3 trials
- Bayer2 trials
- Eisai Inc.2 trials
- Eli Lilly and Company2 trials
- and 10 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Recruiting
Active, not recruiting
Active, not recruiting
A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Immune thrombocytopenia (ITP)2 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple system atrophy1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Study of LY3461767 in Participants With Chronic Heart Failure With Reduced Ejection Fraction
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
Completed
Completed
Completed
A Study of LY3372993 in Participants With Alzheimer's Disease (AD) and Healthy Participants
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026